
|Articles|March 11, 2008
NCPA issues statement on bill that would add human growth hormone to Schedule III
NCPA comments on bill that would classify human growth hormone as Schedule III substance.
Advertisement
The National Community Pharmacists Association has issued a comment on Senate Bill S877/House Bill 4911. The
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Repurposed Drugs Show Modest, Short-Term Benefit for Long COVID Fatigue
2
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol
3
Emerging Data Show Potential Risk of Autoimmune Diseases With GLP-1 Use
4
Drug Shortages Are Down, But That's Not the Win It Sounds Like
5































